September 20, 2014 4:04 AM ET

Commercial Services and Supplies

Company Overview of BayBio

Executive Profile

Glenn Pierce M.D., Ph.D.

Senior Vice President of Global Medical Affairs, Biogen Idec Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships
58--

Background

Dr. Glenn Pierce Ph.D., M.D. serves as senior vice president of Hematology, Cell and Gene Therapies at Biogen Idec Inc. Dr. Pierce serves as Senior Vice President of Hematology, Cell and Gene Therapies of Biogen Idec Hemophilia Therapeutic Area. He served as the Senior Vice President Chief Medical Officer of Biogen Idec Inc. He served as the Chief Medical Officer and Senior Vice President of Biogen Idec Hemophilia Therapeutic Area. Dr. Pierce joined Avigen, Inc. in November ...

Corporate Headquarters

651 Gateway Boulevard
South San Francisco, California 94080

United States

Phone: 650-871-7101
Fax: 650-871-7555

Board Members Memberships

Director

Education

PhD
Case Western Reserve University
MD
Case Western Reserve University
Master's Degree
Washington University, St. Louis

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marc N. Casper Chief Executive Officer, President, Director, Member of Strategy & Finance Committee and Member of Science & Technology Committee
Thermo Fisher Scientific, Inc.
$1.1M
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.3M
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
$15.2M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$2.7M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BayBio, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.